Skip to content

Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.

Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00211627
Enrollment
30
Registered
2005-09-21
Start date
2004-06-30
Completion date
2006-06-30
Last updated
2005-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea Syndromes, Snoring

Brief summary

Study to demonstrate the safety and effectiveness of a new oral enhanced airway device to treat simple snoring.

Detailed description

The Keepasleep airway device is a novel and unique buccopharyngeal airway device to enhance breathing during sleep. This method has not been described in the medical literature and has been successful in limited testing. This clinical trial is to determine the safety and effectiveness of the KEEPASLEEP device utilizing 30 subjects with simple snoring. Each subject will serve as his/her own control. The device augments airflow into the posterior pharynx to minimize airway collapse,tissue vibration, and consequent snoring.The device passes through the retromaxillary space and requires that the subject be absent their wisdom teeth.

Interventions

DEVICEKEEPASLEEP enhanced breathing device

Sponsors

Miller, Chipp St. Kevin, M.D.
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

- 18 yrs. of age or greater * generally good health * Intact dentition / ABSENT upper and lower wisdom teeth ( by extraction or lack of development ) * Simple snoring( documented by observer) or mild sleep apnea RDI \< 15 ( documented by polysomnogram) * Subject must have a concerned observer to assess of sleep and snoring behavior during trial period

Exclusion criteria

- Presence of Wisdom teeth (third molars) * active oral disease * acute illness * BMI (body mass index) \> 30

Design outcomes

Primary

MeasureTime frame
Reduction/Elimination of snoring behavior

Countries

United States

Contacts

Primary ContactChipp K. Miller, M.D.
waycooldoc@aol.com310 829-7792

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026